> ## Content Index
> Fetch the complete content index at: https://www.whiteroseintelligence.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Ciaran Lawlor
- URL: https://www.whiteroseintelligence.com/ciaran-lawlor/
- Published: 1999-01-02T13:40:00.000Z
- Updated: 2025-01-02T02:03:30.000Z
- Author: Liam Sturgess
- Tags: Profiles, #docs, #individual

**Ciaran Lawlor** is an American biotechnology entrepreneur based in Boston, Massachusetts.

## Education

Lawlor graduated from Maynooth University, completing a 3 month lab placement at Kings College London. He then received credentials from the Royal College of Surgeons in Ireland (RCSI).[\[1\]](#fn1)

## Career

From October 2011 to November 2013, Lawlor worked at [PULMATRiX](https://www.whiteroseintelligence.com/PULMATRiX), focusing on “formulation development for pre-clinical studies with small molecules, antibiotics, macromolecules and new chemical entities.”[\[1:1\]](#fn1)

He then went to work at [Moderna](https://www.whiteroseintelligence.com/Moderna), where he “helped build internal capabilities on nanoparticle formulation including growing formulation team and acting as lead delivery technology scientist on key strategic partnerships.”

In January 2016, Lawlor was hired at the [Boston Consulting Group](https://www.whiteroseintelligence.com/Boston-Consulting-Group) (BCG), where he was quickly promoted to Principal.

### COVID-19

Lawlor co-authored a paper titled “The Near-Term Outlook for COVID-19 Therapeutic Treatments” published by the Boston Consulting Group on May 8, 2020\. The paper presented a favourable outlook for the use of the experimental drug remdesivir over a variety of other options to treat COVID-19\. Lawlor's co-authors were Jordon Walker, Ahad Wahid and Josh Kellar.[\[2\]](#fn2)

A follow-up article was published on May 14, 2020, titled “The Timelines and Implications for COVID-19 Vaccines”. It was co-authored with Kellar, Wahid, Emily Serazin, Andrew Rodriguez and Philip Berk.[\[3\]](#fn3)

In April 2021, Lawlor left BCG to become Chief Operating Officer of [ReNAgade Therapeutics](https://www.whiteroseintelligence.com/ReNAgade-Therapeutics).[\[1:2\]](#fn1)[\[4\]](#fn4)

## Patents

- [Inhalable dry powders](https://archive.ph/2023.06.15-003024/https://patents.google.com/patent/US11235112B2/en?q=%28Inhalable+dry+powders%29&oq=Inhalable+dry+powders)
- [Lipid nanoparticle compositions](http://archive.today/2023.06.15-003655/https://patents.google.com/patent/WO2016118724A1/en?oq=2016118724)

## External links

- [Campfire Wiki](https://www.campfire.wiki/doku.php?id=ciaran%5Flawlor)
- [LinkedIn](https://www.linkedin.com/in/ciaran-lawlor-919546b/)

---

1. *Ciaran Lawlor.* LinkedIn. Retrieved June 14, 2023, from <https://www.linkedin.com/in/ciaran-lawlor-919546b/> [↩︎](#fnref1) [↩︎](#fnref1:1) [↩︎](#fnref1:2)
2. Lawlor, C., Wahid, A., Walker, J., & Kellar, J. (2020). *The Near-Term Outlook for COVID-19 Therapeutic Treatments.* Boston Consulting Group. <https://web.archive.org/web/20230422204237/https://web-assets.bcg.com/img-src/BCG-The-Near-Term-Outlook-for-COVID-19-Therapeutic-Treatments-May-2020%5Ftcm9-246799.pdf> [↩︎](#fnref2)
3. Lawlor, C., Kellar, J., Serazin, E., Rodriguez, A., Berk, P., & Wahid, A. (2020, May 14). *The Timelines and Implications for COVID-19 Vaccines.* Boston Consulting Group. <http://archive.today/2023.06.14-235609/https://www.bcg.com/en-ca/publications/2020/covid-vaccines-timelines-implications> [↩︎](#fnref3)
4. *Team.* ReNAgade Therapeutics. Retrieved June 14, 2023, from <https://web.archive.org/web/20230614231455/https://renagadetx.com/team/> [↩︎](#fnref4)